Emergent BioSolutions to Release Third Quarter 2020 Financial Results and Conduct Conference Call on November 5, 2020
15 October 2020 - 9:30PM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, November 5, 2020 at 5:00 pm (Eastern Time) to discuss
the financial results for the third quarter of 2020, recent
business developments, revenue guidance for the fourth quarter of
2020, and financial outlook for full year 2020.
This conference call can be accessed live by
telephone or by webcast:
Live
Teleconference Information:Dial in
number: (855) 766-6521International dial in
number: (262) 912-6157Conference ID: 3549944
Live
Webcast
Information:Visit
https://edge.media-server.com/mmc/p/7c8i4shm for the live webcast
feed.
A replay of the call can be accessed on Emergent’s
website emergentbiosolutions.com under “Investors.”
About Emergent
BioSolutionsEmergent BioSolutions is a global life
sciences company whose mission is to protect and enhance life.
Through our specialty products and contract development and
manufacturing services, we are dedicated to providing solutions
that address public health threats. Through social responsibility,
we aim to build healthier and safer communities. We aspire to
deliver peace of mind to our patients and customers so they can
focus on what’s most important in their lives. In working together,
we envision protecting or enhancing 1 billion lives by 2030. For
more information visit www.emergentbiosolutions.com. Find us on
LinkedIn and follow us on Twitter @emergentbiosolu and Instagram
@life_at_emergent.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280BurrowsR@ebsi.com
Media Contact:Miko B. NeriSenior
Director, Global Communications & Public
Affairs240-631-3392NeriM@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024